“Quest’s Quanum platform sits at a sensitive intersection of patient information and everyday lab work,” said Ross Filipek, CISO at Corsica Technologies.
Quest Diagnostics: unauthorized access to Quanum LSM
Quest Diagnostics revealed yesterday that it experienced a cyber breach. The company said an unauthorized user accessed its Quanum LSM system, the service clients use to place test orders and receive results. At this time the scope of the incident is unknown, and Quest believes that some patient data may have been impacted.
Why the Quanum LSM connection matters, in one expert’s view
Filipek’s observation highlights why access to the Quanum LSM system is significant. He warned that the platform “sits at a sensitive intersection of patient information and everyday lab work.” Depending on what an attacker was able to access, Filipek said, those records could provide material for identity fraud or for persuasive, targeted fraud messages that reference real tests and therefore carry greater credibility than generic phishing attempts.
Filipek also framed a practical defensive takeaway: healthcare organisations should “examine how much patient information each account can reach,” and strengthen monitoring so that “unusual access” is detected before a legitimate workflow becomes a route to records.
Audit-ready is a season. It shouldn't be.
Evidence in spreadsheets, controls drifting between audits, frameworks multiplying on flat headcount. Nubivance runs continuous compliance on Rapid7 Cyber GRC - SOC 2, HIPAA, ISO 27001, PCI, CMMC.
End the scrambleImmediate risks to patients: fraud, targeted scams, and data integrity
Experts quoted in the reporting drew a direct line from exposed health records to several concrete harms. Tim Mackey, Head of Software Supply Chain Risk Strategy at Black Duck, stressed that health information is “arguably the most sensitive personal data available.” He explained how criminals can use such data in highly targeted attacks—for example, a phone call that appears to come from a patient’s clinic, cites elements of that patient’s care plan, and demands payment. Mackey’s point: when an attacker can reference real elements of care, a victim is more likely to comply.
Mackey also described a non-financial harm: the deliberate alteration or “poisoning” of health data. He offered a stark example: if a patient with hypertension had their medication dosage changed in records, that modification “could be catastrophic.” Both Mackey and Filipek used the Quanum incident to underline that cybercriminals are motivated by multiple possible payoffs and that attacks can target both privacy and clinical integrity.
Healthcare cyber trends: a difficult year and rising ransomware
The Quest incident arrives in the context of what the reporting calls “a challenging year for healthcare cybersecurity.” Security experts have voiced broader concerns about the sector’s cyber posture, and research cited by the story indicates that ransomware attacks “doubled for the industry since the same time last year.” Those trends create a backdrop in which breaches of platforms that connect test ordering and results carry heightened operational and reputational consequences.
What this means for technologists, procurement leaders, and patients
- Technologists and security teams: Filipek’s recommendation is concrete: review how much patient information each account can access and improve monitoring to flag unusual access patterns before routine workflows are misused.
- Procurement leaders and vendors (device manufacturers through to providers): Mackey urged investment in threat modelling across the supply chain, noting that every link—from device makers to clinical providers—needs to consider how exposed health data could be abused.
- Patients: The company’s statement that some patient data may be impacted signals a risk of targeted scams and identity fraud; affected individuals will likely need to watch for suspicious communications that reference specific tests or care plans.
The breach at Quest Diagnostics centers on an access point that connects clinicians and patients to laboratory results. With the scope still unknown, the next concrete tasks are internal: determine what records were accessed, notify any affected parties as required, and apply the monitoring and account-access controls Filipek and Mackey recommend. Those measures aim both to limit immediate harm and to blunt the persistent appeal that healthcare data holds for attackers—an appeal the experts quoted say shows little regard for patient well-being.
